NEWS: # ICICI Bank allots shares to BoR shareholders # IT stocks decline as govt hikes MAT # Godrej Properties to raise up to Rs 1,000 cr debt through QIP # Jet Airways to go in for 20% equity dilution # Oil prices slip below $73 in Asian trade # Maruti mulls sixth plant at Manesar # FMCG cos hire in small towns to fire up growth # Sunil Mittal, GM Rao may join new RBI board


LOTUS EYE CARE HOSPITAL LIMITED – Forthcoming IPO

Monday, June 9, 2008 16:24
Posted in category IPO News, Recent Buzz

LOTUS EYE CARE HOSPITAL LIMITED

Symbol – Series LOTUSEY EQ
Issue Period June 12, 2008 to June 17, 2008
Issue Size 1,00,00,000 Equity Shares
Issue Type 100% Book Building
Face Value Rs. 10/-
Price Range Rs 38 to Rs 42
Tick Size Re. 1/-
Market Lot 150 shares
Minimum Order Quantity 150 shares
Maximum Subscription Amount for Retail Investor Rs.100000
IPO Market Timings 10.00 a.m. to 5.00 p.m.
Book Running Lead Manager Keynote Corporate Services Ltd
Co- Book Running Lead Manager Canara Bank- Merchant Banking Division
Syndicate Member Keynote Capitals Limited
Categories FI, IC, VC, MF, FII, FVCI, SIDC, PF, PEF, MLA, BDFI, NIF,BC, IND, HUF, NRI and OTH
No. of Cities with Bidding Centers 48
Inclusion in F&O Segment Not eligible in F&O segment
Name of the registrar S.K.D.C CONSULTANTS LIMITED
Address of the registrar No.11, Seth Narayandas Layout,Street No.1, West Power House Road,Coimbatore – 641 012, Tamil Nadu
Contact person name number and Email id Ms. Vijayalakshmi Narendra Tel No (0422) 6549995 Fax No (0422) 2499574 Email info@skdc-consultants.com
You can leave a response, or trackback from your own site.

Leave a Reply

You must be logged in to post a comment.

Copyright © 2009 ShareGyan.com. All rights reserved.

Disclaimer: Trading or investing in stocks & commodities is a high risk activity. Any action you choose to take in the markets is totally your own responsibility. ShareGyan.com will not be liable for any, direct or indirect, consequential or incidental damages or loss arising out of the use of this information.

Disclosure: The information on this website is neither an offer to sell nor solicitation to buy any of the securities mentioned herein. The writers may or may not be trading in the securities mentioned.